Geranium wallichianum D. Don Ex Sweet Ameliorates Rheumatoid Arthritis by Curtailing the Expression of COX-II and Inflammatory Cytokines as Well as by Alleviating the Oxidative Stress. Issue 3 (8th July 2022)
- Record Type:
- Journal Article
- Title:
- Geranium wallichianum D. Don Ex Sweet Ameliorates Rheumatoid Arthritis by Curtailing the Expression of COX-II and Inflammatory Cytokines as Well as by Alleviating the Oxidative Stress. Issue 3 (8th July 2022)
- Main Title:
- Geranium wallichianum D. Don Ex Sweet Ameliorates Rheumatoid Arthritis by Curtailing the Expression of COX-II and Inflammatory Cytokines as Well as by Alleviating the Oxidative Stress
- Authors:
- Jabeen, Qaiser
Haider, Syed Ihtisham
Asif, Awais
Rasheed, Rubina
Gul, Shaheen
Arshad, Shafia - Abstract:
- Geranium wallichianum D. Don ex sweet traditionally been used as home remedy for backaches, joint pain, colic, and rheumatism. The objective of this study was to investigate the therapeutic benefits of plant in an adjuvant-induced arthritis paradigm. Immune-mediated rheumatoid arthritis was developed by injecting complete Freund's adjuvant (CFA) into the hind paws of rats and the aqueous methanolic crude extract was administered. The animals were physically monitored for changes in paw edema size and arthritic score. Hematological parameters and systemic inflammatory indicators evaluated. Genetic expressions of tumor necrosis factor (TNF-α), interleukins (IL-1β, IL-6), necrosis factor (NF-κB), and cyclooxygenase (COX-II) enzyme were studied using real-time qPCR. PGE2 levels in blood were quantified through Enzyme Linked Immunosorbent Assay (ELISA). On the 14th day, Immunoglobulin E (IGE) exhibited a substantial decline in paw edema and arthritic score. At the doses of 500 mg/Kg ( P ≤ .05) and 1000 mg/Kg ( P ≤ .001), IGE significantly reduced TNF-α, interleukins, and COX-II mRNA expression. IGE significantly lowered the MDA levels at the doses of 500 and 1000 mg/Kg (13.18 ± .70 and 9.04 ± .26 μM/L respectively) as compared to arthritic control (30.82 ± 1.12 μM/L) group. IGE significantly improved the antioxidant enzyme activities of CAT and SOD ( P ≤ .001) in treated animals. TNF-α, interleukins, and COX-II mRNA expression were also significantly reduced at the doses of 300 (Geranium wallichianum D. Don ex sweet traditionally been used as home remedy for backaches, joint pain, colic, and rheumatism. The objective of this study was to investigate the therapeutic benefits of plant in an adjuvant-induced arthritis paradigm. Immune-mediated rheumatoid arthritis was developed by injecting complete Freund's adjuvant (CFA) into the hind paws of rats and the aqueous methanolic crude extract was administered. The animals were physically monitored for changes in paw edema size and arthritic score. Hematological parameters and systemic inflammatory indicators evaluated. Genetic expressions of tumor necrosis factor (TNF-α), interleukins (IL-1β, IL-6), necrosis factor (NF-κB), and cyclooxygenase (COX-II) enzyme were studied using real-time qPCR. PGE2 levels in blood were quantified through Enzyme Linked Immunosorbent Assay (ELISA). On the 14th day, Immunoglobulin E (IGE) exhibited a substantial decline in paw edema and arthritic score. At the doses of 500 mg/Kg ( P ≤ .05) and 1000 mg/Kg ( P ≤ .001), IGE significantly reduced TNF-α, interleukins, and COX-II mRNA expression. IGE significantly lowered the MDA levels at the doses of 500 and 1000 mg/Kg (13.18 ± .70 and 9.04 ± .26 μM/L respectively) as compared to arthritic control (30.82 ± 1.12 μM/L) group. IGE significantly improved the antioxidant enzyme activities of CAT and SOD ( P ≤ .001) in treated animals. TNF-α, interleukins, and COX-II mRNA expression were also significantly reduced at the doses of 300 ( P ≤ .05), 500 ( P ≤ .01) and 1000 mg/Kg ( P ≤ .001) which were expressed as fold changes. This study shows that Geranium wallichianum D. Don ex sweet has a strong potential to alleviate immune-mediated arthritis by lowering oxidative stress and downregulating the proinflammatory cytokines signaling mechanisms. Graphical Abstract … (more)
- Is Part Of:
- Dose-response. Volume 20:Issue 3(2022)
- Journal:
- Dose-response
- Issue:
- Volume 20:Issue 3(2022)
- Issue Display:
- Volume 20, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 20
- Issue:
- 3
- Issue Sort Value:
- 2022-0020-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-07-08
- Subjects:
- rheumatoid arthritis -- complete Freund's adjuvant -- tumor necrosis factor -- ELISA -- qPCR -- superoxide dismutase
Dose-response relationship (Biochemistry) -- Periodicals
Drugs -- Dose-response relationship -- Periodicals
Drugs -- Physiological effect -- Periodicals
Hormesis -- Periodicals
Dose-Response Relationship, Drug -- Periodicals
Dose-response relationship (Biochemistry)
Drugs -- Dose-response relationship
Drugs -- Physiological effect
Periodicals
571.634 - Journal URLs:
- http://journals.sagepub.com/home/dos ↗
http://dos.sagepub.com/ ↗
http://dose-response.metapress.com ↗
http://www.dose-response.com/ ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/614/ ↗
http://www.sagepublications.com/ ↗ - DOI:
- 10.1177/15593258221112649 ↗
- Languages:
- English
- ISSNs:
- 1559-3258
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23588.xml